Oral Testosterone With and Without Concomitant Inhibition of 5α-Reductase by Dutasteride in Hypogonadal Men for 28 Days

PURPOSE: Co-administration of the 5α-reductase inhibitor dutasteride increases the oral testosterone bioavailability in men with experimentally induced hypogonadism. We examined oral testosterone with and without dutasteride administration in hypogonadal men for 28 days. MATERIALS AND METHODS: We ra...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Urol
Hoofdauteurs: Amory, John K., Bush, Mark A., Zhi, Hui, Caricofe, Ralph B., Matsumoto, Alvin M., Swerdloff, Ronald S., Wang, Christina, Clark, Richard V.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2010
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4267472/
https://ncbi.nlm.nih.gov/pubmed/21168874
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.juro.2010.09.089
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items